ESSA Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2024 | 8.75 M | $53.02 M | 0.00% | 19.72% |
| BELLEVUE GROUP AG | 11/14/2024 | 7.88 M | $47.75 M | -0.13% | 17.76% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 4.29 M | $25.99 M | 1.84% | 9.67% |
| MORGAN STANLEY | 11/14/2024 | 4.18 M | $25.34 M | 0.08% | 9.42% |
| RTW INVESTMENTS, LP | 11/14/2024 | 3.26 M | $19.76 M | 41.89% | 7.35% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 2.74 M | $16.62 M | -7.50% | 6.18% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.47 M | $8.93 M | 0.00% | 3.32% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 804,649 | $4.88 M | -0.17% | 1.81% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 677,005 | $4.10 M | 0.00% | 1.53% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 345,902 | $2.10 M | 37.22% | 0.78% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 278,000 | $1.68 M | -11.95% | 0.63% |
| CIBC WORLD MARKET INC. | 11/12/2024 | 73,587 | $446,000 | -8.31% | 0.17% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 62,955 | $381,507 | -0.83% | 0.14% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 46,652 | $282,711 | -0.21% | 0.11% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 41,092 | $249,018 | 19.23% | 0.09% |
| ROYAL BANK OF CANADA | 11/14/2024 | 40,797 | $248,000 | 12.35% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 28,479 | $172,583 | 13.35% | 0.06% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 27,795 | $168,438 | 100.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 26,858 | $162,759 | 0.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 21,000 | $127,260 | 452.63% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 15,100 | $91,506 | -54.38% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 6,000 | $36,360 | 0.00% | 0.01% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5,609 | $33,991 | 100.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 5,162 | $31,000 | 100.00% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 4,050 | $24,543 | 97.56% | 0.01% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 2,500 | $15,150 | 0.00% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 2,417 | $14,647 | 54.44% | 0.01% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 900 | $5,220 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 11/13/2024 | 846 | $5,127 | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 700 | $4,242 | -84.78% | 0.00% |
| LAUREL WEALTH ADVISORS LLC | 11/05/2024 | 600 | $3,636 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/19/2024 | 355 | $2,000 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 21 | $127 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 8 | $48 | 0.00% | 0.00% |
| TORONTO DOMINION BANK | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
ESSA Pharma Inc.institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of ESSA Pharma Inc.. The most heavily invested institutionals were:
BVF INC/IL: 8.75 M
Bellevue Group AG: 7.88 M
Soleus Capital Management, L.P.: 4.29 M
MORGAN STANLEY: 4.18 M
RTW INVESTMENTS, LP: 3.26 M
PFM Health Sciences, LP: 2.74 M
79.12% of ESSA Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 36.98 M shares in the last 24 months. This purchase volume represents approximately $63.97 M in transactions.